CHF Solutions Inc. (CHFS)
Symbol Info
Listed Symbol CHFS
Name CHF Solutions Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $4,998,000
Latest Fiscal EPS $-44.23
Price Info
21 Day Moving Average $2.5779
21 Day EMA $2.589920
50 Day Moving Average $2.7928
50 Day EMA $2.843790
200 Day EMA $9.477960
200 Day Moving Average 6.132410
52 Week High $18.90
52 Week Low $2.15
52 Week Change $-85.500200
Alpha -0.122184
Beta 2.2129
Standard Deviation 0.291163
R2 0.070746
Periods 60
Share Information
10 Day Average Volume 83,016
20 Day Average Volume 77,272
30 Day Average Volume 83,242
50 Day Average Volume 97,668
Outstanding Shares 2,584,972
Float Shares 273,069
Percent Float 10.56%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 13
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months -
Institute Holdings Percent 10.300000
Institute Sold Previous 3 Months 1,287
Insider Holdings Date 2019-03-31
Insider Bought Previous 3 Months 9,523
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 2,311,903
Price Change
7 Day Price Change $0.0994999
7 Day Percent Change 4.08%
21 Day Price Change $-0.1905
21 Day Percent Change -6.98%
30 Day Price Change $-0.3905001
30 Day Percent Change -13.33%
Month To Date Price Change $-0.3105
Month To Date Percent -10.89%
90 Day Price Change $-0.8775
90 Day Percent Change -25.68%
Quarter To Date $-0.3705
Quarter To Date Percent -12.73%
180 Day Price Change $-6.360499
180 Day Percent Change -71.47%
200 Day Price Change $-4.9705
200 Day Percent Change -66.19%
Year To Date $-4.2953
Year To Date Percent -62.84%
Profile
Description CHF Solutions Inc is an early-stage medical device company based in the US. It focuses on commercializing the Aquadex FlexFlow System. The Aquadex FlexFlow System is used for temporary and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It is designed to remove excess fluid ( primarily excess salt and water) from patients suffering from fluid overload who have failed diuretic therapy. The company operates through a single segment being Cardiac and coronary disease products.
Details
Issue Type CS
Market Cap $6,564,536
Sec Type EQS
Auditor Baker Tilly Virchow Krause, LLP
Total Shares Outstanding 2,584,972
CEO John L. Erb
Employees 55
Last Audit UE
Classification
CIK 0001506492
Industry Medical Devices
Sector Healthcare
NAICS Irradiation Apparatus Manufacturing(334517)
Info
Address 12988 Valley View Road
Eden Prairie, MN 55344
Website https://www.chf-solutions.com
Facisimile
Telephone +1 952 345-4200
Email IR@sunshineheart.com
Key Ratios
Profitability
EBIT Margin -306.8
EBITDA Margin -302.7
Pre-Tax Profit Margin -11,194.1
Profit Margin Cont -
Gross Margin 41.80
Profit Margin TOT -
Income Statements
Revenue $5,754,000
Revenue Per Share $2.2259
Revenue 3 Years $-
Revenue 5 Years $127.15
Valuation Measures
PE Ratio -
Enterprise Value $-79,830
Price To Sales 1.140865
Price To Free Cash -0.4
PE High Last 5 Years -
Price To Book 0.8
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 0.8
Financial Strength
Total Debt To Equity 0.1
Int Coverage -
Current Ratio 3.9
Leverage Ratio 1.3
Quick Ratio 3.2
Long Term Debt To Capital 0.04
Assets
Receivables Turnover 3.2
Invoice Turnover 1.70
Assets Turnover 0.20
Management Effectiveness
Return Assets -198.18
Return On Equity -257.07
Return On Capital -242.1
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
CHFS
CHF Soluti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.